>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:
  • OCLR +8.6%, NFLX +6.5%, CHKP +4.3%, MTG +3.7%, UNP +2.9%, TAL +2.8%, WTFC +2.7%, BK +2.6%, PTC +2.4%, KEY +0.7%, BBT +0.6%
M&A news:
  • CYTX +14.5% (to acquire certain assets from Azaya Therapeutics; Cytori to issue $2 mln in common stock up front)
  • PIP +4.4% (PharmAthene and privately-held Altimmune announce merger in an all-stock transaction)
  • NTNX +2.4% (M&A speculation (Cisco for Nutanix) from the Street.com afte
  • HPE bought hyperconverged peer SimpliVity)
  • LQ +1.7% (La Quinta Holdings says pursuing the separation of its businesses into two stand-alone publicly traded companies, which could involve spinning off our owned real estate assets as a separate company)
Select Rail names showing strength after Hunter Harrison steps down as Canadian Pacific CEO to 'pursue opportunities involving other Class 1 Railroads':
  • CSX +16.8%, NSC +3.6%, UNP +2.9%, KSU +2.4%
Other news:
  • SSH +15.3% (continued strength), ABEO +13.7% (EMA has granted Orphan Drug Designation for its gene therapy program ABO-101 for children impacted by Sanfilippo syndrome type B), NVCR +10.1% (announces physicians at 500 cancer treatment centers in the U.S. have been certified to prescribe its Optune to newly diagnosed and recurrent glioblastoma patientsg), SYN +8.5% (confirms plans to initiate a Phase 2b/3 adaptive pivotal trial for SYN-010; anticipates initiating this trial by the end of 1Q17), GALT +6.9% (Richard E. Uihlein discloses 7.89% active stake),MNK +4.2% (modestly rebounding; confirms details regarding FTC / Questcor matter; says no impact on Mallinckrodt net sales and will host call tomorrow at 7:30am ET), TDOC +2.4% (prices 8.25 mln share common stock offering (6.65 mln by Teladoc and 1.6 mln by stockholders) at $16.75/share), PSO +2% (modestly rebounding following yesterday's sell off), BHP +1% (preliminary agreement with federal prosecutors on behalf of Samarco Mineracao SA)
Analyst comments:
  • TSLA +4% (upgraded to Overweight from Equal Weight at Morgan Stanley)
  • MBLY +4% (upgraded to Buy from Neutral at Goldman)
  • HPQ +1.5% (upgraded to Buy from Neutral at UBS)
  • PNRA +1.3% (upgraded to Buy from Neutral at Goldman)
  • SWN +1.3% (upgraded at UBS)